Medtronic's osteocool™ procedure shows significant, swift pain relief and sustained improvement for cancer patients

Dublin, dec. 15, 2020 /prnewswire/ -- medtronic plc (nyse: mdt) today announced the release of outcomes in the first 100 patients treated with the osteocool™ radiofrequency ablation (rfa) system in the opus one clinical study (as referenced below) – the largest, prospective study in rfa...
MDT Ratings Summary
MDT Quant Ranking